Imatinib Completed Phase 4 Trials for Cancer, Breast Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00372476Efficacy and Safety of Imatinib and Vinorelbine in Patients With Advanced Breast Cancer